Searchable abstracts of presentations at key conferences in endocrinology

ea0077p154 | Adrenal and Cardiovascular | SFEBES2021

Retrospective analysis of the screening for primary hyperaldosteronism (PHA) - are we doing enough beyond screening?

Newman Amelia , Purewal Tejpal , Hegde Pallavi

Background: Primary hyperaldosteronism (PHA) is characterised by inappropriately high aldosterone production, most commonly caused by unilateral/bilateral adrenal adenoma or bilateral adrenal hyperplasia. It usually manifest as hypertension and/or hypokalaemia. There is emerging evidence to support the prevalence of PHA in more than 10% in hypertensive patients but only a minority will have a confirmed diagnosis and receive specific treatment.Aim: To pro...